Torti Frank 4
4 · Immunovant, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Torti Frank
Director
Transactions
- Award
Stock Option (right to buy)
2023-04-12+158,292→ 158,292 totalExercise: $14.70Exp: 2033-04-12→ Common Stock (158,292 underlying) - Award
Common Stock
2023-04-12+121,916→ 515,274 total
Footnotes (3)
- [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
- [F2]The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- [F3]Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.